Skip to main content

NICE IDs

21/04/2020
ID1368: Fremanezumab for preventing migraine
21/04/2020
ID1596: Ropeginterferon alfa-2b for treating polycythaemia vera without symptomatic splenomegaly
21/04/2020
ID1213: Dupilumab for treating severe asthma
21/04/2020
ID968: Zynteglo for treating transfusion-dependent beta-thalassaemia
21/04/2020
ID1189: Naldemedine for treating opioid-induced constipation
21/04/2020
ID1522: Atezolizumab with nab-paclitaxel for treating PD L1-positive, triple-negative, advanced breast cancer
16/04/2020
ID1511: Ustekinumab for treating moderately to severely active ulcerative colitis
16/04/2020
ID1504: Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer
16/04/2020
ID1299: Larotrectinib for treating advanced solid tumours with TRK fusions
16/04/2020
ID1484: Gilteritinib for treating relapsed or refractory acute myeloid leukaemia
16/04/2020
ID1547: Avelumab with axitinib for untreated advanced or metastatic renal cell carcinoma
16/04/2020
ID1508: Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant
16/04/2020
ID1414: Esketamine for treatment-resistant depression
16/04/2020
ID1140: Pembrolizumab for untreated metastatic or unresectable recurrent squamous cell head and neck
16/04/2020
ID1467: Elotuzumab with pomalidomide and dexamethasone for treating multiple myeloma after 2 therapies
16/04/2020
ID1516: Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer
16/04/2020
ID1602: Solriamfetol for treating excessive waketime sleepiness caused by narcolepsy
16/04/2020
ID1499: Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea
05/03/2020
ID885: Short bowel syndrome - teduglutide

In development [GID-TA10048] Expected publication date: TBC

26/02/2020
ID927: Afamelanotide for treating erythropoietic protoporphyria

Afamelanotide for treating erythropoietic protoporphyria

Follow AWTTC: